US Stock MEIP Surges Over 33% Today, Market Cap Rises to $124 Million

BlockBeats News, July 19th, MEI Pharma (Nasdaq: MEIP) surged over 33% today, with a market value rising to $41.2431 million.

Earlier, Titan Partners Group and the crypto investment firm GSR are jointly leading the strategic transformation of the U.S. pharmaceutical company MEI Pharma (Nasdaq: MEIP), driving its establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in fund commitments to this project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.